Patent Assignment
Reel/Frame 047960/0001
Assignment of Assignor's Interest
Recorded: 2018-10-24
Pages: 83
Assignor
OREXIGEN THERAPEUTICS, INC.
Executed: 2018-07-27
Assignee
NALPROPION PHARMACEUTICALS, INC.
10 NORTH PARK PLACE, SUITE 201, MORRISTOWN, NEW JERSEY, 07960
Covered Property
(1)
Methods for Reducing Binge or Compulsive Eating
Application:
13/991,372 →
Publication:
US 2013/0252995
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 25, 2013
From: DUNAYEVICH, EDUARDO; MCELROY, SUSAN; LANDBLOOM, RON
To: OREXIGEN THERAPEUTICS, INC.
Reel/Frame 030710/0299 →
Security Agreement
Mar 21, 2016
From: OREXIGEN THERAPEUTICS, INC.
To: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 038180/0021 →
Security Interest
Aug 6, 2018
From: NALPROPION PHARMACEUTICALS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 047288/0321 →
Release of Security Interest
Sep 27, 2019
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: NALPROPION PHARMACEUTICALS, INC.
Reel/Frame 050574/0106 →
Change of Name
Oct 17, 2019
From: NALPROPION PHARMACEUTICALS, INC.
To: NALPROPION PHARMACEUTICALS LLC
Reel/Frame 050750/0497 →
Security Interest
Dec 19, 2019
From: CURRAX PHARMACEUTICALS LLC; NALPROPION PHARMACEUTICALS LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB
Reel/Frame 051377/0958 →